[1] Krutovskikh VA,Piccoli C,Yamasaki H.Gap junction intercellular communication propagates cell death in cancerous cells[J].Oncogene,2002,21(13):1989-1999.
[2] Naus CC,Laird DW.Implications and challenges of connexin connections to cancer[J].Nat Rev Cancer,2010,10(6):435-441.
[3] Vinken M,Vanhaecke T,Papeleu P,et al.Connexins and their channels in cell growth and cell death[J].Cell Signal,2006,18(5):592-600.
[4] 孙华,刘耕陶.细胞间隙连接通讯与肿瘤[J].中国药理学通报,2004,20(11):1205-1208.
[5] Mesnil M,Crespin S,Avanzo JL,et al.Defective gap junctional intercellular communication in the carcinogenic process[J].Biochim Biophys Acta,2005,1719(1/2):125-145.
[6] McLachlan E,Shao Q,Wang HL,et al.Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis[J].Cancer Res,2006,66(20):9886-9894.
[7] Tai MH,Upham BL,Olson LK,et al.Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells[J].Int J Cancer,2007,120(9):1855-1862.
[8] Peterson-Roth E,Brdlik CM,Glazer PM.Src-Induced cisplatin resistance mediated by cell-to-cell communication[J].Cancer Res,2009,69(8):3619-3624.
[9] Dbouk HA,Mroue RM,El-Sabban ME,et al.Connexins:a myriad of functions extending beyond assembly ofgap junction channels[J].Cell Commun Signal,2009,7:4.
[10] McLachlan E,Shao Q,Laird DW.Connexins and gap junctions in mammary gland development and breast cancer progression[J].J Membr Biol,2007,218(1/3):107-121.
[11] McLachlan E,Shao Q,Wang HL,et al.Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis[J].Cancer Res,2006,66(20):9886-9894.
[12] Elzarrad MK,Haroon A,Willecke K,et al.Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to puonary endothelium[J].BMC Med,2008,6:20.
[13] Ito A,Katoh F,Kataoka TR,et al.A role for heterologous gap junctions between melanoma and endothelial cells in metastasis[J].J Clin Invest,2000,105(9):1189-1197.
[14] Li Z,Zhou Z,Donahue HJ.Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential[J].Clin Exp Metastasis,2008,25(3):265-272.
[15] Li Z,Zhou Z,Welch DR,et al.Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs[J].Clin Exp Metastasis,2008,25(8):893-901.
[16] 杨燕,陶亮.细胞缝隙连接与 HSV2TK/GCV系统旁观者效应的关系[J].中国药理学通报,2009,25(1):9-12.
[17] Prise KM,OSullivan JM.Radiation-induced bystander signalling in cancer therapy[J].Nat Rev Cancer,2009,9(5):351-360.
[18] Tang Q,Zhang D,Wan M,et al.Experi mental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer[J].Cancer Biother Radiopharm,2007,22(6):755-761.
[19] Tanaka T,Yamasaki H,Mesnil M.Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes[J].Mol Carcinog,2001,30(3):176-180.
[20] Prise KM,OSullivan JM.Radiation-induced bystander signalling in cancer therapy[J].Nat Rev Cancer,2009,9(5):351-360.
[21] le-Agha N,Stahl W,Sies H.(-)-Epicatechin effects in rat liver epithelial cells:stimulation of gap junctional communication and counteraction of its loss due to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate[J].Biochem Pharmacol,2002,63(12):2145-2149.
[22] Carystinos GD,Alaoui-Jamali MA,Phipps J,et al.Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-transretinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells[J].Cancer Chemother Pharmacol,2001,47(2):126-132.
[23] Sato H,Senba H,Virgona N,et al.Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells[J].Mol Carcinog,2007,46(3):215-224.
[24] Westhoff MA,Zhou S,Bachem MG,et al.Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells[J].Oncogene,2008,27(39):5169-5181.
[25] Gakhar G,Hua DH,Nguyen TA.Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells[J].Anticancer Drugs,2010,21(1):77-88.
[26] Huynh HT,Alpert L,Laird DW,et al.Regulation of the gap junction connexin43 gene by androgens in the prostate[J].J Mol Endocrinol,2001,26(1):1-10.
[27] Mendoza-Naranjo A,Saez PJ,Johansson CC,et al.Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells[J].J Immunol,2007,178(11):6949-6957.
[28] Trepel M,Stoneham CA,Eleftherohorinou H,et al.A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated,vascu-lar-targeted suicide gene transfer[J].Mol Cancer Ther,2009,8(8):2383-2391.
[29] Huang Q,Liu XZ,Kang CS,et al.The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells[J].Cancer Gene Ther,2010,17(3):192-202.
[30] Carystinos GD,Kandouz M,Alaoui-Jamali MA,et al.Unexpected induction of the human connexin 43 promoter by the ras signaling pathway is mediated by a novel putative promoter sequence[J].Mol Pharmacol,2003,63(4):821-831.
[31] Ammerpohl O,Trauzold A,Schniewind B,et al.Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells[J].Br J Cancer,2007,96(1):73-81.
[32] Hagiwara H,Sato H,Ohde Y,et al.5-Aza-2-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene[J].Br J Pharmacol,2008,153(7):1373-1381.
[33] Huang T,Zhu Y,Fang X,et al.Gap junctions sensitize cancer cells to proteasome inhibitor MG132-induced apoptosis[J].Cancer Sci,2010,101(3):713-721.
[34] Nakamura Y,Chang CC,Mori T,et al.Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells[J].Carcinogenesis,2005,26(3):665-671.
[35] Kedde M,Strasser MJ,Boldajipour B,et al.RNA-binding protein Dnd1 inhibits microRNA access to target mRNA[J].Cell,2007,131(7):1273-1286.
[36] Kandouz M,Bier A,Carystinos GD,et al.Connexin43 pseudogene is expressed in tumor cells and inhibits growth[J].Oncogene,2004,23(27):4763-4770.